Dave Muoio

Partners HealthCare VP of Connected Health Joseph Kvedar interviews Aetna EVP and CMO Harold Paz. (Photo by Christopher Huang)

October 19, 2018
Connected Health Conference has drawn to a close, and there was no shortage of launches, deals and insights from healthcare and technology companies big and small. As such, Babyforyou.net.ua has compiled a collection of odds and ends we heard during this year’s three-day show. Aetna's mobile strategy learns from its past Aetna looked to be ahead of the game when it acquired Healthagen, maker of the...
October 19, 2018
WEconnect, maker of an app that helps addiction patients through their first year after substance abuse treatment, announced yesterday that it has closed a $6.05 million Series A round. Investors in the company include ServiceNow founder Fred Luddy, Buckingham Capital Management Chairman Larry Leeds Jr., Metalab founder Andrew Wilkinson, CEO of Venturehouse Mark Ein, and others. The app — which...

Photo by Christopher Huang.

October 18, 2018
The NIH’s All of Us Research Program launched in May with a daunting task ahead of it — collecting demographic, health, behavior and genomic data from a 1 million person cohort comprised of demographics often underrepresented in biomedical research. Speaking this morning at the Connected Health Conference in Boston, Dr. Dara Richardson-Heron, All of Us’ chief engagement officer, said that the...
October 18, 2018
Xcertia, a standards and guidelines body for mobile apps, today announced the draft release of  its updated Privacy and Security Guidelines, a document consisting of practical and descriptive advice for health app designers. The group has opened the draft up for comment from stakeholders and industry members for the next 45 days, Chuck Parker, managing director at Xcertia, said here at the...
October 17, 2018
OptimizeRx, a software company focused on pharma-provider digital health messaging, has completed a $9 million deal to acquire medication adherence and care coordination messaging company CareSpeak Communications, OptimizeRx told Babyforyou.net.ua. With this deal, OptimizeRx will be able to expand its EHR-embedded messaging platform so that phrama and providers can communicate directly with patients...
October 17, 2018
Devoted, a Waltham, Massachusetts-based company that uses technology to blend health insurance with provider services, announced yesterday that it has landed a staggering $300 million Series B investment and is now enrolling Medicare beneficiaries living in eight southern and central Florida counties. The funding round was led by Andreessen Horowitz, with Premji Invest and Uprising also joining...
October 16, 2018
NowRx — an online pharmacy specializing in same-day, same-hour prescription deliveries — announced a $7 million Series A round raised through crowdfunding platform SeedInvest. The company said in a statement that it will use the new backing to continue developing its technology, and expand its service to additional areas within California. "This crowdfunding round provides fantastic validation of...
October 16, 2018
In April of this year, the FDA released a five-point action plan to improve medical device safety that included a clear focus to reduce cybersecurity existing vulnerabilities and promote strong practices for future devices. Since then the agency hasn’t dragged its feet — earlier this month FDA Commissioner Dr. Scott Gottlieb released a lengthy statement announcing the release of a cybersecurity...
October 16, 2018
Hero — a medication adherence system consisting of a countertop device, refill service, and connected app — has launched today to consumers on the back of $12 million in Series A funding. The three-pillar platform is built for patients as well as their caregivers, and looks to reduce the stress and difficulty that each side faces when daily drug regimens begin to escalate, Kal Vepuri, founder and...
October 15, 2018
Proteus Digital Health and Otsuka Pharmaceutical have expanded their partnership on digital therapeutics. On Thursday, Proteus announced that it received $88 million from the pharma company, which will go toward the continued development and commercialization of its ingestible sensor pill platform. Additionally, the five-year deal will also support the investigation of a wider digital medicine...